Advances in HIV prevention and treatment with antiretroviral drugs continue to improve clinical management and outcomes for individuals at risk for and living with HIV, according to updated recommendations of the International Antiviral Society‒USA Panel. Researchers evaluated new data and treatments and established updated recommendations for initiating therapy, monitoring those starting therapy, changing regiments, and preventing HIV infection for individuals at risk. Among the findings:
- Antiretroviral therapy (ART) is recommended for virtually all HIV-infected individuals, as soon as possible after HIV diagnosis.
- Immediate initiation, if clinically appropriate, requires adequate staffing, specialized services, and careful selection of medical therapy.
- An integrase strand transfer inhibitor (InSTI) plus 2 nucleoside reverse transcriptase inhibitors (NRTIs) is generally recommended for initial therapy.
- CD4 cell count, HIV RNA level, genotype, and other laboratory tests for general health and coinfections are recommended at specified points before and during ART.
- Preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and appropriate monitoring is recommended for individuals at risk for HIV.
Saag MS, Benson CA, Gandhi RT, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults. 2018 recommendations of the International Antiviral Society–USA Panel. JAMA. 2018;320(4):379–396. doi:10.1001/jama.2018.8431.
This Week's Must Reads
CVD Events Prevented with New AHA BP Guideline, Circulation; ePub 2018 Nov 19; Bress, et al
USPSTF: Interventions to Prevent Child Maltreatment, JAMA; 2018 Nov 27; US Preventive Services Task Force
Team-Based Primary Care in Chronically Ill Patients, JAMA Intern Med; ePub 2018 Nov 26; Meyers, et al
Rotating Night Shift Work & Risk of T2D, BMJ; ePub 2018 Nov 21; Shan, Li, et al
PUFAs for Primary & Secondary CVD Prevention, Cochrane Library; ePub 2018 Nov 27; Abdelhamid, et al
Must Reads in Infectious Diseases
Healthcare-Associated Infections in US Hospitals, N Engl J Med; 2018 Nov 1; Magill, O’Leary, et al
Gaps in HIV PrEP by Race and Ethnicity, MMWR; 2018 Oct 19; Huang, Zhu, et al
Trends in HPV-Associated Cancers in the US, MMWR; 2018 Aug 24; Van Dyne, Henley, et al
HIV Viral Suppression Trends in the US, Ann Intern Med; ePub 2018 Aug 21; Nance, et al
Antibiotic Use Among US Older Adults, BMJ; ePub 2018 Jul 27; Olesen, Barnett, et al